AU2022264815A1 - Analytical hplc - Google Patents
Analytical hplc Download PDFInfo
- Publication number
- AU2022264815A1 AU2022264815A1 AU2022264815A AU2022264815A AU2022264815A1 AU 2022264815 A1 AU2022264815 A1 AU 2022264815A1 AU 2022264815 A AU2022264815 A AU 2022264815A AU 2022264815 A AU2022264815 A AU 2022264815A AU 2022264815 A1 AU2022264815 A1 AU 2022264815A1
- Authority
- AU
- Australia
- Prior art keywords
- mobile phase
- organic solvent
- radiopharmaceutical
- acid
- hplc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/0093—Radioactive materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/884—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample organic compounds
- G01N2030/8845—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample organic compounds involving halogenated organic compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8859—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2105950.6 | 2021-04-26 | ||
| GBGB2105950.6A GB202105950D0 (en) | 2021-04-26 | 2021-04-26 | Analytical HPLC |
| PCT/EP2022/061004 WO2022229155A1 (en) | 2021-04-26 | 2022-04-26 | Analytical hplc |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2022264815A1 true AU2022264815A1 (en) | 2023-10-26 |
Family
ID=76193425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2022264815A Pending AU2022264815A1 (en) | 2021-04-26 | 2022-04-26 | Analytical hplc |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240302338A1 (https=) |
| EP (1) | EP4330662B1 (https=) |
| JP (1) | JP2024518319A (https=) |
| KR (1) | KR20240000562A (https=) |
| CN (1) | CN117222890A (https=) |
| AU (1) | AU2022264815A1 (https=) |
| CA (1) | CA3217818A1 (https=) |
| ES (1) | ES3050308T3 (https=) |
| GB (1) | GB202105950D0 (https=) |
| IL (1) | IL307946A (https=) |
| PL (1) | PL4330662T3 (https=) |
| WO (1) | WO2022229155A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201915206D0 (en) | 2019-10-21 | 2019-12-04 | Ge Healthcare Ltd | Use of cyclodextrins as a radiostabilizer |
| CN119688861A (zh) * | 2024-11-29 | 2025-03-25 | 中国辐射防护研究院 | 一种生物样本中18f-psma-1007放化纯的液相色谱分析方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5300280A (en) * | 1992-02-14 | 1994-04-05 | Mallinckrodt Medical, Inc. | Stabilized radiopharmaceutical kits |
| ES2398393T3 (es) * | 2002-03-01 | 2013-03-15 | Dyax Corp. | Péptidos de unión a KDR y a VEGF/KDR y su uso en diagnóstico y terapia |
| JP4942953B2 (ja) * | 2005-06-30 | 2012-05-30 | サントリーホールディングス株式会社 | プロシアニジンの分析方法 |
| US8214159B2 (en) * | 2008-12-04 | 2012-07-03 | Siemens Medical Solutions Usa, Inc. | Apparatus and method for automated quality control |
| GB201013808D0 (en) * | 2010-08-18 | 2010-09-29 | Ge Healthcare Ltd | Peptide radiotracer compositions |
| EP2450332A1 (en) * | 2010-10-22 | 2012-05-09 | Bayer Pharma Aktiengesellschaft | Compounds for use in Imaging, diagnosing and/or treatment of diseases of the central nervous system (F-D2-Deprenyl) |
| GB201202420D0 (en) * | 2012-02-13 | 2012-03-28 | Ge Healthcare Ltd | Radiotracer compositions |
| CN104718299B (zh) * | 2012-08-13 | 2024-02-06 | 通用医院公司 | 用于线粒体复合物i的定量定位的系统和方法 |
| GB201303830D0 (en) * | 2013-03-04 | 2013-04-17 | Univ Glasgow | Methods,unit and device relating to the manufacture,processing,synthesising or screening of radiopharmaceutical compositions |
| GB201418893D0 (en) * | 2014-10-23 | 2014-12-10 | Univ Hull | Monolithic body |
| GB201805253D0 (en) * | 2018-03-29 | 2018-05-16 | Ge Healthcare Ltd Ip | Solid phase extraction |
| CN111333638A (zh) * | 2020-03-17 | 2020-06-26 | 四川大学华西医院 | 18f标记的异喹啉并哒嗪酮类化合物及其合成方法和应用 |
-
2021
- 2021-04-26 GB GBGB2105950.6A patent/GB202105950D0/en not_active Ceased
-
2022
- 2022-04-26 CA CA3217818A patent/CA3217818A1/en active Pending
- 2022-04-26 KR KR1020237040178A patent/KR20240000562A/ko active Pending
- 2022-04-26 AU AU2022264815A patent/AU2022264815A1/en active Pending
- 2022-04-26 EP EP22725757.3A patent/EP4330662B1/en active Active
- 2022-04-26 JP JP2023565467A patent/JP2024518319A/ja active Pending
- 2022-04-26 US US18/557,528 patent/US20240302338A1/en active Pending
- 2022-04-26 CN CN202280031268.4A patent/CN117222890A/zh active Pending
- 2022-04-26 IL IL307946A patent/IL307946A/en unknown
- 2022-04-26 WO PCT/EP2022/061004 patent/WO2022229155A1/en not_active Ceased
- 2022-04-26 PL PL22725757.3T patent/PL4330662T3/pl unknown
- 2022-04-26 ES ES22725757T patent/ES3050308T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20240000562A (ko) | 2024-01-02 |
| EP4330662A1 (en) | 2024-03-06 |
| EP4330662B1 (en) | 2025-09-03 |
| PL4330662T3 (pl) | 2025-11-12 |
| JP2024518319A (ja) | 2024-05-01 |
| IL307946A (en) | 2023-12-01 |
| ES3050308T3 (en) | 2025-12-19 |
| CN117222890A (zh) | 2023-12-12 |
| US20240302338A1 (en) | 2024-09-12 |
| CA3217818A1 (en) | 2022-11-03 |
| WO2022229155A1 (en) | 2022-11-03 |
| EP4330662C0 (en) | 2025-09-03 |
| GB202105950D0 (en) | 2021-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2419096B1 (en) | Stabilization of radiopharmaceutical compositions using ascorbic acid | |
| EP4330662B1 (en) | Analytical hplc | |
| Gustafsson et al. | Combined PET and microdialysis for in vivo estimation of drug blood-brain barrier transport and brain unbound concentrations | |
| US9161998B2 (en) | Method and kit for preparing a radiopharmaceutical | |
| Meisenheimer et al. | Ethanol effects on 68Ga-radiolabelling efficacy and radiolysis in automated synthesis utilizing NaCl post-processing | |
| CA2672262C (en) | Radioactive diagnostic imaging agent | |
| Ioppolo et al. | Development of a high‐performance liquid chromatography method for rapid radiochemical purity measurement of [18F] PSMA‐1007, a PET radiopharmaceutical for detection of prostate cancer | |
| HK40109526B (en) | Analytical hplc | |
| HK40109526A (en) | Analytical hplc | |
| Wadsak et al. | 18F fluoroethylations: different strategies for the rapid translation of 11C-methylated radiotracers | |
| Sadeghpour et al. | Evaluation of radiochemical purities of some radiopharmaceuticals in Shiraz Namazi teaching hospital | |
| Waterhouse et al. | Synthesis of [1–11C] Butanol via a facile solid phase extraction protocol | |
| JP2019001761A (ja) | 腫瘍イメージング剤、及びホウ素中性子捕捉療法用腫瘍治療剤 | |
| EP3339309B1 (en) | Radioactive halogen-labeled pyrido[1,2-a]benzimidazole derivative compound | |
| Almeida et al. | Absolute quantitation of iodine-123 epidepride kinetics using single-photon emission tomography: comparison with carbon-11 epidepride and positron emission tomography | |
| JP2024522770A (ja) | 標識化ステップ中に低い含水量を有する、［１８ｆ］放射性標識された化合物を調製するための方法 | |
| Frey et al. | Development of a tomographic myelin scan | |
| Pehlivanoglu et al. | Development and validation of a UV-Radio-HPLC method to assess chemical and radiochemical purity of [68Ga] Ga-PSMA-11 | |
| KR101850479B1 (ko) | [18F]플루오로-도파의 중성 pH 안정화 방법 | |
| Passannante et al. | Pharmacokinetic Evaluation of New Drugs Using a Multi-Labelling Approach and PET Imaging: Application to a Drug Can-didate with Potential Application in Neuromuscular Disorders. Biomedicines 2023, 11, 253 | |
| JP6527736B2 (ja) | 放射性医薬組成物 | |
| Lindner et al. | An automated liquid chromatographic plasma analysis of amino acids used in combination with positron emission tomography (PET) for determination of in vivo plasma kinetics | |
| Nakao et al. | 1-Minute quality control tests for positron emission tomography radiopharmaceuticals | |
| Nakao et al. | A simplified radiometabolite analysis procedure for PET radioligands using a solid phase extraction with micellar medium | |
| Gurin et al. | SELECTION OF MOBILE PHASE SYSTEMS FOR CHROMATOGRAPHIC RESEARCH OF 177 Lu-DOTAELA |